CSF3 and neoplasm: Nevertheless, the tumor-promoting functions of immature neutrophils or G-MDSCs should be considered when treating neutropenic cancer patients with G-CSF, which leads to the generation of even more G-MDSCs (Luyckx et al, 2012; Marini et al, 2017).